ARTICLE | Clinical News
Feraccru ferric maltol regulatory update
February 9, 2015 8:00 AM UTC
Shield said EMA accepted for review an MAA for oral Feraccru ferric maltol to treat iron deficiency anemia in patients with inflammatory bowel disease (IBD) and those intolerant of oral ferrous therap...